Altered lipoprotein processing was also observed in regard to apolipoprotein A2 (apoA2) and deviant C terminal processing associated with IPMN progression to malignancy. This evidence concerns the gene APOA2 and pancreatic intraductal papillary-mucinous neoplasm.